Synthesis and biological evaluation of novel N1-phenylsulphonyl indole derivatives as potent and selective 5-HT6R ligands for the treatment of cognitive disorders. (Q51348713)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 November 2016

Language	Label	Description	Also known as
English	Synthesis and biological evaluation of novel N1-phenylsulphonyl indole derivatives as potent and selective 5-HT6R ligands for the treatment of cognitive disorders.	scientific article published on 3 November 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/27806648

Synthesis and biological evaluation of novel N1-phenylsulphonyl indole derivatives as potent and selective 5-HT6R ligands for the treatment of cognitive disorders. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/27806648

author name string

Ramakrishna V S Nirogi

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/27806648

Thrinath Reddy Bandyala

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/27806648

Pamuletinarasimha Reddy Gangadasari

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/27806648

Mukkanti Khagga

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/27806648

publication date

3 November 2016

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/27806648

Journal of Enzyme Inhibition and Medicinal Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/27806648

31

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/27806648

sup1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/27806648

1-15

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/27806648

The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Effective pharmacologic management of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Update on the use of memantine in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists.

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

(3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: potent and selective antagonists of the serotonin 5-HT6 receptor

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Synthesis and SAR of 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines as potent serotonin 5-HT6 receptor antagonists.

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Synthesis and pharmacological evaluation of aryl aminosulfonamide derivatives as potent 5-HT(6) receptor antagonists

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists.

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Synthesis of substituted diphenyl sulfones and their structure-activity relationship with the antagonism of 5-НТ6 receptors.

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

A three-dimensional pharmacophore model for 5-hydroxytryptamine6 (5-HT6) receptor antagonists.

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Synthesis of cycloalkane-annelated 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines and their evaluation as 5-HT6 receptor antagonists

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Cloning of the mouse 5-HT6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

The effects of neurotoxic lesions of the perirhinal cortex combined to fornix transection on object recognition memory in the rat.

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2015.1103233

21 January 2018

Identifiers

10.3109/14756366.2015.1103233

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/27806648

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/27806648

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51348713&oldid=1294869552"